Impact of Sociodemographic Characteristics on the Quality of Care in the Surgical Management of Endometrial Cancer: An Analysis of a National Database in the United States

Benoit, Louise; Pauly, Lea; Phelippeau, Juliette; Koskas, Martin

doi:10.1159/000506048

Cited by 5 publications

(4 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding was consistent with other studies that have demonstrated an increase in cancer research papers from China [17,18]. In addition, we noticed that not only Chinese scholars, but also scholars from France [19,20], South Korea [21,22], Japan [23], Italy [24], and Switzerland [25], have used the SEER database to conduct clinical cancer research.…”

Section: Discussionsupporting

confidence: 92%

Analysis of the Trends in Publications on Clinical Cancer Research in Mainland China from the Surveillance, Epidemiology, and End Results (SEER) Database: Bibliometric Study

Lin¹,

Lian²,

Zhou³

et al. 2020

JMIR Med Inform

View full text Add to dashboard Cite

Background The application of China’s big data sector in cancer research is just the beginning. In recent decades, more and more Chinese scholars have used the Surveillance, Epidemiology, and End Results (SEER) database for clinical cancer research. A comprehensive bibliometric study is required to analyze the tendency of Chinese scholars to utilize the SEER database for clinical cancer research and provide a reference for the future of big data analytics. Objective Our study aimed to assess the trend of publications on clinical cancer research in mainland China from the SEER database. Methods We performed a PubMed search to identify papers published with data from the SEER database in mainland China until August 31, 2020. Results A total of 1566 papers utilizing the SEER database that were authored by investigators in mainland China were identified. Over the past years, significant growth in studies based on the SEER database was observed (P<.001). The top 5 research topics were breast cancer (213/1566, 13.6%), followed by colorectal cancer (185/1566, 11.8%), lung cancer (179/1566, 11.4%), gastrointestinal cancer (excluding colorectal cancer; 149/1566, 9.5%), and genital system cancer (93/1566, 5.9%). Approximately 75.2% (1178/1566) of papers were published from the eastern coastal region of China, and Fudan University Shanghai Cancer Center (Shanghai, China) was the most active organization. Overall, 267 journals were analyzed in this study, of which Oncotarget was the most contributing journal (136/267, 50.9%). Of the 1566 papers studied, 585 (37.4%) were published in the second quartile, 489 (31.2%) in the third quartile, 312 (19.9%) in the first quartile, and 80 (5.1%) in the fourth quartile, with 100 (6.4%) having an unknown Journal Citation Reports ranking. Conclusions Clinical cancer research based on the SEER database in mainland China underwent constant and rapid growth during recent years. High-quality and comprehensive cancer databases based on Chinese demographic data are urgently needed.

show abstract

Section: Discussionsupporting

confidence: 92%

Analysis of the Trends in Publications on Clinical Cancer Research in Mainland China from the Surveillance, Epidemiology, and End Results (SEER) Database: Bibliometric Study

Lin¹,

Lian²,

Zhou³

et al. 2020

JMIR Med Inform

View full text Add to dashboard Cite

show abstract

“…Conversely, the mortality caused by endometrial cancer had been found to be the highest among women of low socioeconomic status, 25 possibly because of reduced evidence‐based care. 26 …”

Section: Introductionmentioning

confidence: 99%

Cancer of the corpus uteri: 2021 update

Koskas¹,

Amant

Mirza

et al. 2021

Intl J Gynecology & Obste

Self Cite

196

116

View full text Add to dashboard Cite

Endometrial cancer is the most common gynecological malignancy in high‐ and middle‐income countries. Although the overall prognosis is relatively good, high‐grade endometrial cancers have a tendency to recur. Recurrence needs to be prevented since the prognosis for recurrent endometrial cancer is dismal. Treatment tailored to tumor biology is the optimal strategy to balance treatment efficacy against toxicity. Since The Cancer Genome Atlas defined four molecular subgroups of endometrial cancers, the molecular factors are increasingly used to define prognosis and treatment. Standard treatment consists of hysterectomy and bilateral salpingo‐oophorectomy. Lymphadenectomy (and increasingly sentinel node biopsy) enables identification of lymph node‐positive patients who need adjuvant treatment, including radiotherapy and chemotherapy. Adjuvant therapy is used for Stage I–II patients with high‐risk factors and Stage III patients; chemotherapy is especially used in non‐endometrioid cancers and those in the copy‐number high molecular group characterized by TP53 mutation. In advanced disease, a combination of surgery to no residual disease and chemotherapy with or without radiotherapy results in the best outcome. Surgery for recurrent disease is only advocated in patients with a good performance status with a relatively long disease‐free interval.

show abstract

“…2 The mortality rate is higher in low socio-economic countries due to a lack of evidence-based care. 3,4 The management essentially includes surgical staging followed by adjuvant treatment in the form of radiotherapy and/or chemotherapy. Adjuvant radiotherapy is delivered through external beam radiation therapy (EBRT) and intravaginal brachytherapy (IVBT).…”

Section: Introductionmentioning

confidence: 99%

Single catheter 3D volume-based hybrid inverse planning optimisation in IVBT can improve organ sparing

Barik,

Jena,

Sahoo

et al. 2023

J Radiother Pract

View full text Add to dashboard Cite

Purpose: To analyse the dosimetric benefit of the hybrid inverse planning optimisation (HIPO) planning method over the graphical optimisation (GrO) planning method for 3D volume-based intravaginal brachytherapy (IVBT) in a mono-centre patient cohort. Material and methods: Twenty-five patients surgically staged with endometrial cancer were considered for the study. All the patients had received adjuvant IVBT for three fractions with one-time computed tomography image-based planning. The data on the patient, tumour, plan, and treatment characteristics were retrieved from the database. All the plans were re-optimised with GrO and HIPO techniques for this comparison study. The different dosimetric parameters were compared between the two methods, and the collected data were tabulated and shown graphically. The statistical evaluation was performed with IBM SPSS version 26, and Origin Pro 8.5 was employed for plots. Results: HIPO plans show similar target coverage in terms of D 90(%), V 95(%) and conformity index with no significant statistical difference from the GrO plans with an acceptable increase in homogeneity index (0·087 ± 0·062%). It succeeds in achieving a statistically significant reduction of dose to organs at risk such as D0·1 cc, D1·0 cc and D2·0 cc for the bladder (11·59%, 4·8% and 3·99%), rectum (41·33%, 16·9% and 16·05%) and sigmoid (20·97%, 13·53% and 11·21%), respectively, in comparison with GrO optimisation. Conclusion: Considering the dosimetric outcome of 3D-based IVBT, it is suggested to adopt inverse optimisation techniques like HIPO over GrO to achieve higher quality treatment plan in terms of adequate target dose and lesser dose to OARs.

show abstract

Impact of Sociodemographic Characteristics on the Quality of Care in the Surgical Management of Endometrial Cancer: An Analysis of a National Database in the United States

Cited by 5 publications

References 21 publications

Analysis of the Trends in Publications on Clinical Cancer Research in Mainland China from the Surveillance, Epidemiology, and End Results (SEER) Database: Bibliometric Study

Analysis of the Trends in Publications on Clinical Cancer Research in Mainland China from the Surveillance, Epidemiology, and End Results (SEER) Database: Bibliometric Study

Cancer of the corpus uteri: 2021 update

Single catheter 3D volume-based hybrid inverse planning optimisation in IVBT can improve organ sparing

Contact Info

Product

Resources

About